Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

161 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Whole body metabolic effects of prolonged endurance training in combination with erythropoietin treatment in humans: a randomized placebo controlled trial.
Christensen B, Nellemann B, Larsen MS, Thams L, Sieljacks P, Vestergaard PF, Bibby BM, Vissing K, Stødkilde-Jørgensen H, Pedersen SB, Møller N, Nielsen S, Jessen N, Jørgensen JO. Christensen B, et al. Am J Physiol Endocrinol Metab. 2013 Oct 1;305(7):E879-89. doi: 10.1152/ajpendo.00269.2013. Epub 2013 Aug 6. Am J Physiol Endocrinol Metab. 2013. PMID: 23921143 Free article. Clinical Trial.
Fat content in liver and skeletal muscle changes in a reciprocal manner in patients with acromegaly during combination therapy with a somatostatin analog and a GH receptor antagonist: a randomized clinical trial.
Madsen M, Krusenstjerna-Hafstrøm T, Møller L, Christensen B, Vendelbo MH, Pedersen SB, Frystyk J, Jessen N, Hansen TK, Stødkilde-Jørgensen H, Flyvbjerg A, Jørgensen JO. Madsen M, et al. J Clin Endocrinol Metab. 2012 Apr;97(4):1227-35. doi: 10.1210/jc.2011-2681. Epub 2012 Feb 1. J Clin Endocrinol Metab. 2012. PMID: 22298804 Clinical Trial.
High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition.
Poulsen MM, Vestergaard PF, Clasen BF, Radko Y, Christensen LP, Stødkilde-Jørgensen H, Møller N, Jessen N, Pedersen SB, Jørgensen JO. Poulsen MM, et al. Diabetes. 2013 Apr;62(4):1186-95. doi: 10.2337/db12-0975. Epub 2012 Nov 28. Diabetes. 2013. PMID: 23193181 Free PMC article. Clinical Trial.
Insulin resistance after a 72-h fast is associated with impaired AS160 phosphorylation and accumulation of lipid and glycogen in human skeletal muscle.
Vendelbo MH, Clasen BF, Treebak JT, Møller L, Krusenstjerna-Hafstrøm T, Madsen M, Nielsen TS, Stødkilde-Jørgensen H, Pedersen SB, Jørgensen JO, Goodyear LJ, Wojtaszewski JF, Møller N, Jessen N. Vendelbo MH, et al. Am J Physiol Endocrinol Metab. 2012 Jan 15;302(2):E190-200. doi: 10.1152/ajpendo.00207.2011. Epub 2011 Oct 25. Am J Physiol Endocrinol Metab. 2012. PMID: 22028408 Free PMC article. Clinical Trial.
Rosiglitazone decreases bone mass and bone marrow fat.
Harsløf T, Wamberg L, Møller L, Stødkilde-Jørgensen H, Ringgaard S, Pedersen SB, Langdahl BL. Harsløf T, et al. J Clin Endocrinol Metab. 2011 May;96(5):1541-8. doi: 10.1210/jc.2010-2077. Epub 2011 Mar 2. J Clin Endocrinol Metab. 2011. PMID: 21367933 Clinical Trial.
161 results